Completed Heart, Stroke & Blood Pregnancy, Children & Inherited Conditions

Effect of Remote Ischaemic Conditioning on clinical outcomes in st-segment elevation myocardial infarction patients undergoing Primary Percutaneous Coronary Intervention (ERIC-PPCI): A multi-centre randomised controlled clinical study

In plain English

AI plain-English summary

A blood pressure cuff on the arm, inflated and deflated in short cycles during a heart attack, could reduce long-term damage to the heart muscle. Heart attacks kill or disable more people in the UK than any other disease. Even when doctors rapidly reopen the blocked artery with a stent—the current best treatment—many patients still develop heart failure or die within years because the heart muscle has been permanently injured. The damage happens largely during the first few minutes of blood flow returning, a process called reperfusion injury. This trial tests whether a simple, non-invasive cuff technique—remote ischaemic conditioning—applied during the emergency procedure can limit that injury and improve survival. If the technique works, it would be a cheap, widely available intervention that could be added to standard care in every cardiac catheter lab in the country, with no new equipment or specialist training. It would not replace stents or drugs, but could reduce the number of patients who go on to develop heart failure, cutting hospital readmissions and improving quality of life for tens of thousands of people each year. The trial is a randomised controlled study across multiple UK and Danish hospitals, directly measuring clinical outcomes over the long term.

View original technical description
Ischaemic heart disease (IHD) is the leading cause of death and disability in the UK. For patients presenting with an acute ST-segment elevation myocardial infarction (STEMI), timely myocardial reperfusion using primary percutaneous coronary intervention (PPCI) is the most effective therapy for limiting myocardial infarct (MI) size, a major determinant of prognosis. However, morbidity and mortality following PPCI remain significant. Therefore, novel therapeutic interventions are required to reduce MI size and improve clinical outcomes post-PPCI. Remote ischaemic conditioning (RIC), a low-cost therapeutic intervention (in which multiple cycles of non-lethal limb ischaemia and reperfusion are non-invasively induced by a cuff placed on the upper arm), has been reported to reduce MI size in STEMI patients undergoing PPCI. However, whether RIC can improve long-term clinical outcomes in PPCI patients is unknown, and is investigated in the ERIC-PPCI study, a UK-Denmark multi-centre randomised controlled trial.

View the original record at the funder ↗

Researchers

Derek Hausenloy (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Remote Ischaemic Conditioning for secondary PREVENTion after stroke (RIC-PREVENT) – a single centre, pilot randomised controlled trial.
Remote Ischaemic Conditioning After Stroke 3 (RECAST-3): A multicentre randomised controlled trial
A study to assess the feasibility and effects of introducing remote ischaemic preconditioning in elective abdominal aortic aneurysm repair
Remote Ischaemic Conditioning After Stroke 3 (RECAST-3): A multicentre randomised controlled trial.
Targeting the sphingosine-1 phosphate pathway to reduce myocardial ischemia / reperfusion injury

Original classification

Clinical Study

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.